RMX Industries Secures $295,550 Financing from Vanquish Group
RMX Industries, Inc. has secured a $295,550 financing deal with Vanquish Funding Group to enhance working capital, with potential for $1.1 million more.
Canopy Growth shareholders approve key proposals at AGM
Canopy Growth Corp. held its Annual General Meeting, where shareholders approved the election of directors and an auditor, among other proposals.
Tempus AI, Inc. Secures $192.5 Million in Data Agreements
Tempus AI, Inc. announces $192.5 million agreements with Bristol-Myers Squibb and Pathos AI to enhance oncology and neurology data access.
Arcosa Completes Merger with CRH Americas, Changes Control
Arcosa, Inc. has finalized its merger with CRH Americas, transforming its operational structure and impacting the fabricated structural metal products industry.
Steele Bancorp reports Q3 2026 earnings drop post-merger
Steele Bancorp, Inc. announces a significant decline in Q3 2026 earnings, reflecting the impact of its merger with Northumberland Bancorp.
UWM Holdings reports Q3 2026 results, announces rights offering
UWM Holdings Corp reveals preliminary Q3 2026 financial results and launches a rights offering to raise up to $400 million.
LKQ Corporation appoints Salvatore Abbate as new CEO
LKQ Corporation announces Salvatore A. Abbate as new CEO, succeeding Justin L. Jude, effective December 15, 2026, enhancing leadership in the vehicle parts sector.
Winnebago Industries Enters Cooperation Agreement with Vision One
Winnebago Industries announces a cooperation agreement with Vision One Fund, including new director nomination and governance changes.
TeraWulf increases credit facility to $400 million in amendment
TeraWulf Inc. amends credit agreement, boosting revolving credit facility to $400 million, enhancing its financial strength in the finance services sector.
Transocean announces merger with Valaris, pending approvals
Transocean Ltd. reveals a merger with Valaris Limited, a strategic move in the drilling oil and gas wells sector, pending shareholder approvals.
Eastern Bankshares Reports Strong Q3 Earnings and Dividend
Eastern Bankshares, Inc. announces strong Q3 2026 earnings, highlighting growth and a quarterly dividend of $0.15 per share.
Gentex reports third-quarter results amid industry challenges
Gentex Corporation announces third-quarter financial results, showing resilience despite challenges in the automotive sector. Revenue declines noted.
Oric Pharmaceuticals updates on enozertinib program at ESMO
Oric Pharmaceuticals presents promising enozertinib data and plans Phase 3 trial for 2027, impacting the oncology pharmaceutical sector.
World Acceptance reports strong Q2 results, boosts buyback
World Acceptance Corporation posts strong Q2 results with increased net income and revenues, alongside a share repurchase announcement.
Intelligent Protection Management Corp. Enters Major Acquisition
Intelligent Protection Management Corp. announces a strategic acquisition of Advanced Technology Distributors Inc., enhancing its capabilities in IT services.
SLB LIMITED/NV Reports Third-Quarter 2026 Financial Results
SLB LIMITED/NV announces third-quarter 2026 results with revenue growth but a decline in net income. Key insights for the oil and gas field services sector.
Booz Allen Hamilton reports Q2 results, raises earnings guidance
Booz Allen Hamilton reports Q2 fiscal 2027 results, showing revenue decline but increased adjusted net income. Earnings guidance raised amid strong operational execution.
First Citizens BancShares authorizes $1.2B share buyback program
First Citizens BancShares Inc. announces a $1.2 billion share repurchase program for 2027, signaling confidence in its financial health and strategy.
Zai Lab secures $250 million in private placement funding
Zai Lab Ltd announces a $250 million private placement to enhance its pharmaceutical pipeline and operations, reflecting strong investor interest in the sector.
Lunai Bioworks to Delist from Nasdaq Amid Financial Struggles
Lunai Bioworks Inc. announces voluntary delisting from Nasdaq due to financial issues, impacting the pharmaceutical preparations sector.